13.先天性夜盲症之基因療法產品 voretigene neparvovec-rzyl,所使用之基因載體為何?
(A)clustered regularly interspaced short palindromic repeats(CRISPR)
(B)viral vector
(C)zinc finger nuclease(ZFN)
(D)transcription activator-like effector nuclease(TALEN)
答案:登入後查看
統計: A(25), B(73), C(13), D(11), E(0) #3041917
統計: A(25), B(73), C(13), D(11), E(0) #3041917